AU6217186A - Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment - Google Patents

Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment

Info

Publication number
AU6217186A
AU6217186A AU62171/86A AU6217186A AU6217186A AU 6217186 A AU6217186 A AU 6217186A AU 62171/86 A AU62171/86 A AU 62171/86A AU 6217186 A AU6217186 A AU 6217186A AU 6217186 A AU6217186 A AU 6217186A
Authority
AU
Australia
Prior art keywords
desferriferrithiocine
desferrioxamine
pharmaceutical composition
malaria treatment
malaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62171/86A
Inventor
Albrecht Jung
Erich Stahel
Klaus Dieter Vosbeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU6217186A publication Critical patent/AU6217186A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU62171/86A 1985-09-03 1986-09-02 Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment Abandoned AU6217186A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH378485 1985-09-03
CH3784/85 1985-09-03

Publications (1)

Publication Number Publication Date
AU6217186A true AU6217186A (en) 1987-03-05

Family

ID=4263403

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62171/86A Abandoned AU6217186A (en) 1985-09-03 1986-09-02 Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment

Country Status (12)

Country Link
EP (1) EP0214933A3 (en)
JP (1) JPS6256425A (en)
AU (1) AU6217186A (en)
DK (1) DK418386A (en)
IL (1) IL79900A0 (en)
MW (1) MW6386A1 (en)
NZ (1) NZ217431A (en)
OA (1) OA08406A (en)
PH (1) PH23235A (en)
ZA (1) ZA866649B (en)
ZM (1) ZM7286A1 (en)
ZW (1) ZW18186A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733985B1 (en) * 1995-05-10 1997-07-18 Univ Lille Sciences Tech ORGANOMETALLIC COMPLEXES OF ANTI-MALARIA IRON
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
EP1488791A3 (en) * 1998-09-21 2005-04-06 University Of Florida Research Foundation, Inc. Antimalarial agents
CN1585639A (en) 1998-09-21 2005-02-23 佛罗里达大学研究基金会 Antimalarial agents
WO2005034949A1 (en) 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
ES2614086T3 (en) 2005-04-04 2017-05-29 University Of Florida Research Foundation, Inc. Desferritiocin polyether analogs
AU2008229472B2 (en) 2007-03-15 2013-03-14 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
ES2761200T3 (en) 2011-12-16 2020-05-19 Univ Florida Uses of 4'-deferritiocin analogs
EP3071201A4 (en) 2013-11-22 2017-04-26 University of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
WO2016176343A1 (en) 2015-04-27 2016-11-03 University Of Florida Research Foundation, Incorporated Metabolically programmed metal chelators and uses thereof

Also Published As

Publication number Publication date
NZ217431A (en) 1990-01-29
ZM7286A1 (en) 1987-09-30
ZW18186A1 (en) 1987-03-25
EP0214933A2 (en) 1987-03-18
EP0214933A3 (en) 1989-05-24
OA08406A (en) 1988-06-30
DK418386A (en) 1987-03-04
ZA866649B (en) 1987-04-29
MW6386A1 (en) 1987-12-09
DK418386D0 (en) 1986-09-02
JPS6256425A (en) 1987-03-12
IL79900A0 (en) 1986-12-31
PH23235A (en) 1989-06-06

Similar Documents

Publication Publication Date Title
GR862464B (en) Pharmaceutical composition
GB8602787D0 (en) Pharmaceutical composition
GB8602788D0 (en) Pharmaceutical composition
IL79672A0 (en) Process for the preparation of crystalline torasemide and pharmaceutical compositions containing it
GB8530796D0 (en) Pharmaceutical composition
PT83260A (en) Process for the preparation of spergualin telated compounds and of pharmaceutical compositions containing them
AU6287786A (en) Therapeutic composition
AU5706486A (en) Pharmaceutical compositions containing pyridinone compounds
AU6217186A (en) Pharmaceutical composition of desferrioxamine b or desferriferrithiocine for malaria treatment
GB8613320D0 (en) Pharmaceutical composition
PT82464A (en) Process for the preparation of novel benzisoselenazolonyl derivatives and of pharmaceutical compositions containing the same
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
AU6656886A (en) Pharmaceutical composition of suprofen
AU587505B2 (en) Pharmaceutical compositions
GB2177913B (en) Pharmaceutical composition for combating malaria
AU589429B2 (en) Novel 11-methylene-oestr-15-enes, processes for their preparation, and pharmaceutical compositions
AU584266B2 (en) Azoniaspironortropanol esters, processes for the preparation thereof and pharmaceutical compositions containing them
GR3000306T3 (en) Composition for the treatment of infections
PT82228A (en) Process for the preparation of compounds of imidazo-isoquinoline and imidazo-tienopyridine and of pharmaceutical compositions therewith
AU4975185A (en) Pharmaceutical compositions of anhydroerythromycin
AU579718B2 (en) Substituted 1,8-naphthyridionones, processes for their preparation and pharmaceutical compositions containing them
PH20397A (en) Pharmaceutical composition for combating malaria
IL82293A0 (en) Pharmaceutical compositions for the treatment of malaria
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria
AU7819887A (en) Pharmaceutical composition